The stage of testing for a drug or biological product, defined by the FDA into five categories: Early Phase 1, Phase 1, Phase 2, Phase 3, and Phase 4. Each phase has different objectives and participant numbers. Non-drug studies (like device or behavioral studies) are marked as “Not Applicable.”

Protocol

Study registry

Source

Early Phase 1 (formerly listed as Phase 0)Phase 1